Advances in Pharmaceutical and Biomedical Sciences

Convalescent Plasma (CP) therapy has been used for over a century to treat infectious diseases, including SARS, MERS, and H1N1. In response to the Covid-19 pandemic, this book explores the use of CP as a therapeutic strategy for critically ill patients. By transfusing plasma rich in antibodies from recovered individuals, CP boosts the immune response and aids in the recovery process. The book highlights the methodology, donor selection criteria, and clinical outcomes, alongside evidence from early studies showing promising results in Covid-19 treatment. It serves as a comprehensive guide for medical professionals exploring this adaptive immunotherapy.

---